TerrAscend (TSNDF) Asset Writedowns and Impairment (2021 - 2026)

TerrAscend's (TSNDF) quarterly Asset Writedowns and Impairment came in at $239000.0 in Q1 2026, down 50.21% year-on-year from $480000.0 in Q1 2025, and down 64.7% on a QoQ basis from $677000.0 in Q4 2025.

TerrAscend (TSNDF) Asset Writedowns and Impairment (2021 - 2026) Analysis & Trends

TerrAscend (TSNDF) has 6 years of Asset Writedowns and Impairment data on file, last reported at $239000.0 in Q1 2026.

  • On a quarterly basis, Asset Writedowns and Impairment fell 50.21% year-over-year to $239000.0 in Q1 2026; TTM through Mar 2026 was $1.4 million, a 70.56% decrease from a year earlier, with the FY2025 full-year figure at $1.7 million, down 45.48% from the prior year.
  • Asset Writedowns and Impairment for Q1 2026 stood at $239000.0, down from $677000.0 in the prior quarter.
  • Over the last five years, Asset Writedowns and Impairment for TSNDF reached as high as $152.9 million in Q3 2022 and fell as low as -$7.3 million in Q4 2022.
  • Historically, Asset Writedowns and Impairment has averaged $9.2 million across 5 years, with a median of $314000.0 in 2025.
  • On a YoY basis, Asset Writedowns and Impairment climbed as much as 39314.43% in 2022 and fell as far as 572.06% in 2022.
  • Year by year, Asset Writedowns and Impairment stood at -$7.3 million in 2022, then jumped by 90.04% to -$728000.0 in 2023, then surged by 675.55% to $4.2 million in 2024, then sank by 83.84% to $677000.0 in 2025, then sank by 64.7% to $239000.0 in 2026.
  • Per Business Quant data, the three most recent Asset Writedowns and Impairment figures were $239000.0 in Q1 2026, $677000.0 in Q4 2025, and $314000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 TerrAscend 160.44 Mn 162.98 Mn 34.60 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 239,000.00
Mar 31, 2026 239,000.00
Dec 31, 2025 677,000.00
Dec 31, 2025 677,000.00
Sep 30, 2025 314,000.00
Sep 30, 2025 314,000.00
Jun 30, 2025 193,000.00
Jun 30, 2025 193,000.00
Mar 31, 2025 480,000.00
Mar 31, 2025 480,000.00
Dec 31, 2024 4.19 Mn
Dec 31, 2024 4.19 Mn
Sep 30, 2024 183,000.00
Sep 30, 2024 183,000.00
Jun 30, 2024 -20,000.00
Jun 30, 2024 -20,000.00
Mar 31, 2024 2.44 Mn
Mar 31, 2024 2.44 Mn
Dec 31, 2023 -728,000.00
Dec 31, 2023 -728,000.00